PIPERAZIN-1-YL-TRIFLUOROMETHYL-SUBSTITUTED-PYRIDINES AS FAST DISSOCIATING DOPAMINE 2 RECEPTOR ANTAGONISTS

The present invention relates to piperazin-1-yl-trifluoromethyl-substituted-pyridines that are fast dissociating dopamine 2 receptor antagonists, processes for preparing these compounds, pharmaceutical compositions comprising these com-pounds as an active ingredient. The compounds find utility as me...

Full description

Saved in:
Bibliographic Details
Main Authors MACDONALD, GREGOR JAMES, BARTOLOME-NEBREDA, JOSE MANUEL, VAN GOOL, MICHIEL LUC MARIA
Format Patent
LanguageEnglish
French
Published 13.09.2016
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The present invention relates to piperazin-1-yl-trifluoromethyl-substituted-pyridines that are fast dissociating dopamine 2 receptor antagonists, processes for preparing these compounds, pharmaceutical compositions comprising these com-pounds as an active ingredient. The compounds find utility as medicines for treating or preventing central nervous system disor-ders, for example schizophrenia, by exerting an antipsychotic effect without motor side effects. La présente invention porte sur des pyridines substituées par un groupe pipérazin-1-yl-trifluorométhyle qui sont des antagonistes des récepteurs D2 de la dopamine à dissociation rapide, sur des procédés de préparation de ces composés, sur des compositions pharmaceutiques comprenant ces composés en tant que principe actif. Les composés trouvent une utilité en tant que médicaments pour le traitement ou la prévention de troubles du système nerveux central, par exemple la schizophrénie, en exerçant un effet antipsychotique sans effets secondaires moteurs. Formule (I).
AbstractList The present invention relates to piperazin-1-yl-trifluoromethyl-substituted-pyridines that are fast dissociating dopamine 2 receptor antagonists, processes for preparing these compounds, pharmaceutical compositions comprising these com-pounds as an active ingredient. The compounds find utility as medicines for treating or preventing central nervous system disor-ders, for example schizophrenia, by exerting an antipsychotic effect without motor side effects. La présente invention porte sur des pyridines substituées par un groupe pipérazin-1-yl-trifluorométhyle qui sont des antagonistes des récepteurs D2 de la dopamine à dissociation rapide, sur des procédés de préparation de ces composés, sur des compositions pharmaceutiques comprenant ces composés en tant que principe actif. Les composés trouvent une utilité en tant que médicaments pour le traitement ou la prévention de troubles du système nerveux central, par exemple la schizophrénie, en exerçant un effet antipsychotique sans effets secondaires moteurs. Formule (I).
Author VAN GOOL, MICHIEL LUC MARIA
BARTOLOME-NEBREDA, JOSE MANUEL
MACDONALD, GREGOR JAMES
Author_xml – fullname: MACDONALD, GREGOR JAMES
– fullname: BARTOLOME-NEBREDA, JOSE MANUEL
– fullname: VAN GOOL, MICHIEL LUC MARIA
BookMark eNqFissKwjAQAHvQg69vMD8Q0Cr0vCZpu9AmIbs91EspEkGQtlD_H3vw7mkYZrbJahiHuEleHr0JcEcrz7KtJAfMq8YFVxsuF6fmRozcsNHStwE1WkMCSORALDQSOYXAaAuhnYd6ySIVwSjj2QUBlqFwFolpn6yf_XuOhx93yTE3rEoZp7GL89Q_4hA_nYI0u5yy7Kou_48vWZQ3mg
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate PYRIDINES SUBSTITUEES PAR PIPERAZIN-1-YL-TRIFLUOROMETHYLE EN TANT QU'ANTAGONISTES DES RECEPTEURS D2 DE LA DOPAMINE A DISSOCIATION RAPIDE
ExternalDocumentID CA2730774C
GroupedDBID EVB
ID FETCH-epo_espacenet_CA2730774C3
IEDL.DBID EVB
IngestDate Fri Jul 19 13:13:27 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_CA2730774C3
Notes Application Number: CA20092730774
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160913&DB=EPODOC&CC=CA&NR=2730774C
ParticipantIDs epo_espacenet_CA2730774C
PublicationCentury 2000
PublicationDate 20160913
PublicationDateYYYYMMDD 2016-09-13
PublicationDate_xml – month: 09
  year: 2016
  text: 20160913
  day: 13
PublicationDecade 2010
PublicationYear 2016
RelatedCompanies JANSSEN PHARMACEUTICA NV
RelatedCompanies_xml – name: JANSSEN PHARMACEUTICA NV
Score 3.0507193
Snippet The present invention relates to piperazin-1-yl-trifluoromethyl-substituted-pyridines that are fast dissociating dopamine 2 receptor antagonists, processes for...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title PIPERAZIN-1-YL-TRIFLUOROMETHYL-SUBSTITUTED-PYRIDINES AS FAST DISSOCIATING DOPAMINE 2 RECEPTOR ANTAGONISTS
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160913&DB=EPODOC&locale=&CC=CA&NR=2730774C
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3LT8IwGG8QjXpT1OC7B7PbIuzB4LCY0m1Qwx7ZOgNeyF5ELoPIjP--XxdQL9zafknTfsnve7TfA6GnrEg0YwGeKqiCXNaKTJMHCyWRe32jyPUEbGhDJDi7Xm8ca69TfdpAH7tcmLpO6HddHBEQlQHeq1per_8esaw6tnLznC5hafXicNOStt5xtyfKXErW0LQD3_KpRKlJieSFJmjpDlg69AAdghFtCCzYb0ORk7L-r1CcM3QUwF5ldY4aRdlCJ3TXd62Fjt3tdzcMt8jbXKBlwAI7JO_MA29sNpF5yJxJ7Ie-a_MxzKN4GHHGYxBEcjALmSW6aWASYYdEHFtMVG9khDNvhC0_IC6QsYJDm9oB90NMPE5GvsciHl2iR8fmdCzDmee_7JlTsruceoWa5aos2gh3inSQJJraT_uKludGkivgGGhqpnSSXDX0a9Tet8vNftItOhVMFvESXfUONavPr-IelHKVPtT8_AFbD4oA
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3LT8IwGG8QjXhT1OCTHsxui7ANBofFlG5j1b2ydQa8kL2IXAaRGf99vy2gXry1_ZKm_ZLf92i_B0IPaR4r6hI8VVAFmajkqSKOl1IsDkdqng1isKHVKsHZcYdWpDzPBrMGet_nwtR1Qr_q4oiAqBTwXtbyevP7iKXXsZXbx2QFS-snk2u6sPOO-8OqzKWgTzTD93SPCpRqlAhuoIGW7oGlQw_QIRjYaoUF43VS5aRs_ioU8xQd-bBXUZ6hRl60UYvu-6610bGz--6G4Q5523O08plvBOSNueCNzW2RB8y0Iy_wHINbMA-jScgZj0AQif48YHrVTQOTEJsk5FhnVfVGRjhzp1j3fOIAGUs4MKjhcy_AxOVk6rks5OEF6poGp5YIZ178sGdByf5y8iVqFusi7yDcy5NxHCvyKBlJSpapcSaBY6DIqdSLM1kdXKHOf7tc_0_qopbFHXthM_flBp1UDK9iJ_ryLWqWH5_5HSjoMrmvefsNAI6M8w
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=PIPERAZIN-1-YL-TRIFLUOROMETHYL-SUBSTITUTED-PYRIDINES+AS+FAST+DISSOCIATING+DOPAMINE+2+RECEPTOR+ANTAGONISTS&rft.inventor=MACDONALD%2C+GREGOR+JAMES&rft.inventor=BARTOLOME-NEBREDA%2C+JOSE+MANUEL&rft.inventor=VAN+GOOL%2C+MICHIEL+LUC+MARIA&rft.date=2016-09-13&rft.externalDBID=C&rft.externalDocID=CA2730774C